Table 2.
Response to therapy based on several variables
| Parameters | Negative response | Positive response | p (χ2) | |||
|---|---|---|---|---|---|---|
| n | Percentage | n | Percentage | |||
| Age | ||||||
| < 45 | 15 | 25.8 | 8 | 13.8 | 0.060 | |
| ≥ 45 | 14 | 24.1 | 21 | 36.2 | ||
| Sex | ||||||
| Male | 24 | 41.4 | 17 | 29.3 | 0.043 | |
| Female | 5 | 8.6 | 12 | 20.7 | ||
| Stage | ||||||
| III | 8 | 13.8 | 14 | 31.1 | 0.104 | |
| IV A | 21 | 29.3 | 15 | 25.9 | ||
| Time when the first symptoms appear | ||||||
| < 6 months | 11 | 18.9 | 12 | 20.7 | 0.788 | |
| ≥ 6 months | 18 | 31.1 | 17 | 29.3 | ||
| VEGF-A level | ||||||
| Low | 11 | 18.9 | 20 | 34.5 | 0.012 | |
| High | 18 | 31.1 | 9 | 15.5 | ||
| LDH level | ||||||
| Low | 8 | 13.8 | 18 | 31.1 | 0.008 | |
| High | 21 | 36.2 | 11 | 18.9 | ||
LDH – lactate dehydrogenase, VEGF – vascular endothelial growth factor